Results from the PRODIGE 13 trial, presented at ESMO Virtual Congress 2020, show that optimisation of diagnostic procedures in terms of overall survival benefits remains to be determined
Dr Susana Banerjee summarises results from two surveys investigating the psychological impact of the pandemic on medical oncologists
Although disappointing, results from IONESCO and PRINCEPS trials are preliminary
The delivery of precision medicine is still restricted by clinicians’ capability to interpret the genomic alterations and match them with the most appropriate medicines
Dr Alessandra Curioni-Fontecedro shares her perspectives on the pitfalls of peer reviewing and its impact on the scientific community and the society
Dr Dario Trapani comments on a study revealing cancer burden projections for 2020 among European Union Member States that provides quality data to formulate informed health policies.
Held virtually for the first time this year, ESMO’s annual congress is connecting the oncology community to improve cancer care in the COVID-19 era
Sex- and gender-sensitive medicine postulates that differences in biological sex, gender identity, role and relations all impact health and disease, and may have implications for prevention, screening, diagnosis and treatment. Its goal is to learn from these differences to improve care and treatment for men and women.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
